financetom
Business
financetom
/
Business
/
Adani Group market capitalisation at six-month high, TAQA says 'no truth' to deal with group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adani Group market capitalisation at six-month high, TAQA says 'no truth' to deal with group
Aug 18, 2023 3:11 AM

All ten Adani Group companies - Adani Enterprises, Adani Ports, Adani Transmission, Adani Green Energy, Adani Total Gas, Adani Wilmar, Adani Power, ACC, Ambuja and NDTV have seen a sharp surge in trade on Friday. The surge has taken the group's overall market capitalisation back above the Rs 11 lakh crore mark for the first time since February this year.

Share Market Live

NSE

Adani Group companies like Adani Enterprises, Ports and others are trading with gains between 3-10 percent in a sudden surge.

Today's surge has also taken Adani Enterprises' market capitalisation back above the mark of Rs 3 lakh crore for the first time since May 23 this year.

Adani Group stocks have been in focus recently after a newspaper report suggested that the Abu Dhabi National Energy Company PJSC (TAQA) is evaluating an investment of up to $2.5 billion in the group's power business. TAQA is the second-largest stock on the Abu Dhabi Securities Exchange.

However, TAQA has mentioned that there is 'no truth' to the reported deal with the Adani Group, according to Bloomberg. Adani Transmission also clarified to the exchanges that it has not engaged with TAQA for an investment in the company.

Adani Power was another stock in focus through the week after GQG Partners bought 31 crore shares or over 8 percent of the company's total equity.

The Adani Group stocks saw significant correction from their highs earlier this year after a report from short-seller Hindenburg Research. Market regulator SEBI has sought another 15 days to submit its report to the Supreme Court.

After the significant correction, Adani Group companies have seen a sharp recovery from their lows. The group crossed the Rs 10 lakh crore market capitalisation mark in May this year and has added another Rs 1 lakh crore in the next three months.

Both Adani Enterprises and Adani Ports are currently the top two gainers on the Nifty 50 index.

First Published:Aug 18, 2023 12:11 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
Mar 11, 2024
March 11 (Reuters) - Assure Holdings Corp ( IONM ): * ASSURE HOLDINGS ENTERS INTO AGREEMENT TO SELL CERTAIN OF ITS ASSETS TO MPOWERHEALTH * ASSURE HOLDINGS CORP ( IONM ): TO SELL CERTAIN ASSETS OF ITS IONM BUSINESS TO MPOWERHEALTH FOR UP TO $4.5 MILLION Source text for Eikon: Further company coverage: ...
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Mar 11, 2024
05:26 PM EDT, 03/11/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on March 08, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,717,897. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 115,374 shares of the company, with 115,374 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002541/xslF345X03/primarydocument.xml Price: 215.82, Change: +0.19, Percent...
Walgreens settles New York charges it inflated prices of infant formula
Walgreens settles New York charges it inflated prices of infant formula
Mar 11, 2024
NEW YORK (Reuters) - Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage. Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made...
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of schizophrenia in a late-stage study. Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval...
Copyright 2023-2025 - www.financetom.com All Rights Reserved